Environmental circulation of adenovirus 40/41 and SARS-CoV-2 in the context of the emergence of acute hepatitis of unknown origin
View ORCID ProfileElke Wollants, View ORCID ProfileEls Keyaerts, View ORCID ProfileLize Cuypers, View ORCID ProfileMandy Bloemen, View ORCID ProfileMarijn Thijssen, View ORCID ProfileSien Ombelet, View ORCID ProfileJoren Raymenants, View ORCID ProfileKurt Beuselinck, View ORCID ProfileLies Laenen, Lore Budts, View ORCID ProfileBram Pussig, View ORCID ProfileKatrien Lagrou, View ORCID ProfileMarc Van Ranst, View ORCID ProfileEmmanuel André
doi: https://doi.org/10.1101/2022.06.08.22276091
Elke Wollants
1KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Els Keyaerts
1KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
2University Hospitals Leuven, Department of Laboratory Medicine, COVID-19 federal testing platform, Leuven, Belgium
Lize Cuypers
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
Mandy Bloemen
1KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Marijn Thijssen
1KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Sien Ombelet
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium
Joren Raymenants
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium
Kurt Beuselinck
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
Lies Laenen
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
Lore Budts
2University Hospitals Leuven, Department of Laboratory Medicine, COVID-19 federal testing platform, Leuven, Belgium
Bram Pussig
5KU Leuven, Department of Public Health and Primary Care, Academic Center for General Practice, Leuven, Belgium
Katrien Lagrou
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium
Marc Van Ranst
1KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
Emmanuel André
2University Hospitals Leuven, Department of Laboratory Medicine, COVID-19 federal testing platform, Leuven, Belgium
3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted June 09, 2022.
Environmental circulation of adenovirus 40/41 and SARS-CoV-2 in the context of the emergence of acute hepatitis of unknown origin
Elke Wollants, Els Keyaerts, Lize Cuypers, Mandy Bloemen, Marijn Thijssen, Sien Ombelet, Joren Raymenants, Kurt Beuselinck, Lies Laenen, Lore Budts, Bram Pussig, Katrien Lagrou, Marc Van Ranst, Emmanuel André
medRxiv 2022.06.08.22276091; doi: https://doi.org/10.1101/2022.06.08.22276091
Environmental circulation of adenovirus 40/41 and SARS-CoV-2 in the context of the emergence of acute hepatitis of unknown origin
Elke Wollants, Els Keyaerts, Lize Cuypers, Mandy Bloemen, Marijn Thijssen, Sien Ombelet, Joren Raymenants, Kurt Beuselinck, Lies Laenen, Lore Budts, Bram Pussig, Katrien Lagrou, Marc Van Ranst, Emmanuel André
medRxiv 2022.06.08.22276091; doi: https://doi.org/10.1101/2022.06.08.22276091
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2908)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12679)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4534)
- Geriatric Medicine (412)
- Health Economics (723)
- Health Informatics (2897)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (918)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4302)
- Nursing (233)
- Nutrition (631)
- Oncology (2250)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6884)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (208)
- Urology (178)